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ABSTRACT
BACKGROUND AND PURPOSE: Cross-sectional imaging of the temporal bone is challenging because of the complexity and small
dimensions of the anatomic structures. We evaluated the role of ﬂat panel angiography in the cross-sectional imaging of the temporal
bone by comparing its image quality and radiation dose with a 64-section multisection CT scanner.
MATERIALS AND METHODS: We retrospectively collected 29 multisection CT and 29 ﬂat panel angiography images of normal whole-
head temporal bones. Image quality was assessed by 2 neuroradiologists, who rated the visualization of 30 anatomic structures with a
3-point ordinal scale. The radiation dose was assessed with an anthropomorphic phantom.
RESULTS: Flat panel angiography showed better image quality than multisection CT in depicting the anterior and posterior crura of the
stapes, the footplate of the stapes, the stapedius muscle, and the anterior ligament of the malleus (P .05). In contrast, multisection CT
showed better image quality than ﬂat panel angiography in assessing the tympanic membrane, the bone marrow of the malleus and incus,
the tendon of the tensor tympani, the interscalar septum, and the modiolus of the cochlea (P  .05). Flat panel angiography had a
signiﬁcantly higher overall image quality rating thanmultisectionCT (P .035). A reduction of the effective dose of approximately 40%was
demonstrated for ﬂat panel angiography compared with multisection CT.
CONCLUSIONS: Flat panel angiography shows strengths and weaknesses compared with multisection CT. It is more susceptible to
artifacts, but due to the higher spatial resolution, it shows equal or higher image quality in assessing some bony structures of diagnostic
interest. The lower radiation dose is an additional advantage of ﬂat panel angiography.
ABBREVIATIONS: FPA ﬂat panel angiography; FPCT ﬂat panel CT; HT equivalent dose; MSCT multisection CT; TLD thermoluminescent dosimeter
Cross-sectional imaging of the temporal bone is challengingbecause of the complexity and small dimensions of the ana-
tomic structures. Multisection CT (MSCT) represents the tech-
nique of choice for the study of the temporal bones. It is nonin-
vasive and provides a high spatial resolution (0.4 mm in-plane
and 0.5 mm in section thickness) that allows radiologists to
visualize most of the anatomic structures and detect pathologic
changes.1 On occasion, however, more invasive examinations,
such as an exploratory operation, may be required to achieve a
diagnosis or to clarify the pathologic processes depicted by
MSCT.2
Flat panel CT (FPCT) has recently provided an alternative
method with ultra-high isotropic spatial resolution (150 
150  150 m3).3,4 Some studies have investigated the image
quality of FPCT in the delineation of postmortem normal tempo-
ral bone anatomy: FPCT showed higher image quality compared
with MSCT when isolated temporal specimens were scanned but
showed similar image quality in cadaveric whole-head speci-
mens.1,2,3,5 The diagnostic value of FPCT has been reported to be
high in the assessment of conductive hearing loss.6
All these studies have been using prototype scanners or dedi-
cated scanners to performFPCTof the temporal bone. Radiologic
assessment of the fine bony structures of the ear can also be per-
formedwith angiographic systems equippedwith flat panel detec-
tors, but the use of this technique is still uncommon. Recently, flat
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panel angiography (FPA) was used in the cross-sectional imaging
assessment of cochlear implants and metallic prostheses after
middle ear reconstructive surgery because it is less susceptible to
metallic artifacts.7-9 However, the image quality of FPA of the
normal temporal bone has not yet been investigated in patients
during clinical practice, and radiation exposure has not been as-
sessed so far, to our knowledge. It was our expectation that FPA
could provide better image quality at lower radiation exposure
compared with MSCT.
The purpose of our study was to test the value of FPA in the
cross-sectional imaging of the temporal bone in a cohort of pa-
tients during clinical practice by comparing its image quality and
radiation dose with those in 64-section MSCT.
MATERIALS AND METHODS
Patients
The use of FPA in our department began in January 2015 for the
postoperative assessment of patients with cochlear implants,7 af-
ter its radiation exposurewas tested on a phantom.Thereafter, the
use of FPA was extended to other clinical indications on the basis
of its proved image quality. FPA and MSCT were randomly
performed. FPA was always preferred to MSCT because of the
results of the phantom dose experiments (see the “Radiation
Dose Assessment” paragraph in the “Results” section) but was
performed whenever the unit was available, the latter being
largely dedicated to endovascular procedures. Otherwise MSCT
was performed.
For this study, from January 2015, we collected 29 consecutive
MSCT scans and 29 consecutive FPA scans of normal temporal
bones, obtained in our department. Temporal boneswere defined
as normal according to the following criteria: 1) no pathologic
findings onMSCT or FPA, and 2) no history of otologic disorders
on the imaged side as evidenced by the patient’s medical record.
Each examination was performed to investigate or rule out sus-
pected abnormalities in the contralateral temporal bone, includ-
ing cholesteatoma, otosclerosis, middle and inner ear congenital
malformations, and complications of otitis.
This retrospective study received review board approval; pa-
tient informed consent was waived.
MSCT and FPA Protocols
MSCT examinations were performed with a 64-section CT scan-
ner (OptimaCT660; GEHealthcare,Milwaukee,Wisconsin). The
MSCT scan included both temporal bones, with the following
scan parameters: current, 200mA; voltage, 120 kV; pitch, 0.531:1;
rotation time, 1 second; section collimation, 0.625 mm; FOV, 22
cm2; matrix, 512 512; scan length, 105 mm. The scan time was
5.63 seconds. The CT dose index volume was 62.1 mGy, and the
dose-length was 652 mGy cm. The images were reconstructed
from the raw data with a 512  512 matrix and a 10-cm FOV,
leading to a 0.195 0.195 mm pixel size in the plane of acquisi-
tion. A bone sharpening filter (Bone Plus; GE Healthcare) was
used.
FPAwas performed with an angiographic system (Allura Xper
FD20; Philips Healthcare, Best, the Netherlands), including a dig-
ital flat panel detector, 30 40 cmwith a source-to-image-recep-
tor distance of 120 cm. The FPA scan included both temporal
bones of the patient’s head, with the following scan parameters:
current, 260 mA; voltage, 80 kV; FOV, 20  15 cm2; voxel size,
0.14 0.14 0.14 mm3; scan height, 150 mm. By rotating 240°
(from 60° to 300°) passing through the posterior part of the head
and avoiding the anterior part, the pivoting C-arm of the angiog-
raphy unit acquires a volume dataset of up to 622 projections,
with a scan time of 25 seconds. The dose-area product was 10,650
mGy  cm2, and the air kerma was 121 mGy. Each temporal
bone was reprocessed separately into a small FOV. Postpro-
cessing of this volume dataset was performed with reconstruc-
tion software (Allura 3D-RA 6.3.0/XperCt 3.1.0; Philips
Healthcare), offering all the possibilities of standard 3D-post-
processing such as multiplanar reformations, curved reforma-
tions, volume-rendering technique, shaded surface display
technique, and MIP. Depending on the number of additional
procedures running, the average reconstruction time was ap-
proximately 10 minutes.
Assessment of Image Quality
Two neuroradiologists with3 years of experience in otoradiol-
ogy independently evaluated each examination separately on a
PACS viewer. The readers were permitted to scroll through the
image sections, change the CT window level and width, perform
MPR and MIP of the volume data, and zoom in and out in any
order.
First, the radiologists defined each scan as adequate or inade-
quate according to the presence of artifacts, including headmove-
ments. Thirty anatomic structures were identified, listed in On-
line Table 1. For each of the structures, the investigators rated the
quality of visualization with an ordinal scale as follows: Zero in-
dicated that the anatomic structure could not be identified; 1, the
anatomic structure could be identified but was not well-delin-
eated from the surrounding structures; and 2, the anatomic struc-
ture could be identified and was well-delineated from the sur-
rounding structures. For each examination, the summed score
represented the overall image quality, ranging from 0 to 60 points
(maximum, 2 points  30 structures). The 2 readers’ average
scores (continuous variables) were used to compare differences
between MSCT and FPA.
Furthermore, each reader placed a circular ROI (approxi-
mately 50 mm2) in the inner portion of the external acoustic ca-
nal, avoiding surrounding bony structures and the tympanic
membrane. The signal was defined as the mean CT attenuation
value within the ROI, and the noise, as the SD of the CT attenua-
tion values within the ROI. The signal-to-noise ratio was calcu-
lated. The 2 readers’ average signal, noise, and SNR were used to
compare MSCT and FPA.
Nominal variables were represented as relative percentages,
and continuous variables were represented as the mean SD. A
2 test for nominal data and aMann-Whitney test for continuous
data were used to compare MSCT and FPA. The Kolmogorov-
Smirnov test was used to test the normality of the continuous
variables, and an unpaired Student t test or Mann-Whitney test
was used to compare the 2 groups, as appropriate. The Spearman
rank correlation coefficient was used to assess the degree of cor-
relation between SNR and the summed score for each group. To
analyze the interobserver agreement, we dichotomized into 2
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groups (“visualized” 1; and “not visualized” 0). The observ-
ers’ sensitivity in detecting each anatomic structure was calcu-
lated, and interobserver agreement was expressed as a percentage
of agreement. The  statistic, which estimates the proportion of
interobserver agreement above that expected by chance, was com-
puted for each anatomic structure. Differences were considered
statistically significant with P  .05. The statistical analysis was
performed with SPSS 20 statistical software (IBM, Armonk,
New York).
Radiation Dose Assessment
We used an anthropomorphic Rando Alderson phantom (Rando
Alderson Research Laboratories, Long Island, City, New York) for
radiation dose assessment. The phantom represented an average
male and was composed of a human skeleton embedded in tissue-
equivalent material. A thermoluminescent dosimeter (TLD) (GR-
200ThermoluminescentDetector; 360RAD,Beijing,China) consist-
ing of LiF,Mg, Cu, andPmaterials (https://www.thermofisher.com/
order/catalog/product/SCP18815) with an intrinsic dose detector
limit of approximately 1 microsievert (Sv) was used. The TLDs
were inserted into the Rando phantom at sites corresponding to or-
gans or tissues (listed in On-line Table 2) of interest in the head and
neck region.10 In addition, we placed TLDs outside on the phantom
orbits to estimate the dose on the eye lenses. Four TLDs were placed
at eachsite toobtain theaverage, theSD,andthevariationcoefficient.
For each technique (MSCT and FPA), 3 scans were obtained to pro-
videamore reliablemeasureof radiation in thedosimeters,minimiz-
ing the changes related to the phantom positioning.
Estimation percentages of irradiated tissue were retrieved
from the literature and used to calculate the equivalent dose (HT)
to a tissue or organ in Sv.10,11 Effective dose (E), expressed in
Sv, was calculated with the following equation: EwTHT,
where E is the product of the tissue-weighting factor (wT), which
represents the relative contribution of that organ or tissue to the
overall risk, and the HT. The whole body was found by the sum-
mation of the weighted equivalent doses to all tissues or organs
exposed. The International Commission on Radiologic Protec-
tion 103/2007 tissue-weighting factors were used to calculate E.12
RESULTS
Image Quality Assessment
All 29 MSCT and FPA scans were considered adequate by both
readers. In particular, no FPA scan showed excessive head move-
ment, necessitating the repetition of the examination. TheMSCT
and FPA groups did not differ in age (49.0  6.9 versus 46.8 
12.5 years; P  .466), sex (female/male: 19:10 versus 18:11; P 
.785), or side (right/left: 16:13 versus 15:14; P .792). MSCT had
higher signal (938.4 21.0 versus 767.0 86.8; P .001), lower
noise (61.5 14.4 versus 236.2 44.0;P .001), and higher SNR
(16.39 3.8 versus 3.5 1.1; P .001) compared with FPA.
MSCT showed better image quality than FPA in assessing the
tympanicmembrane, bonemarrow of themalleus and incus, ten-
don of tensor tympani, interscalar septum and modiolus of the
cochlea (all statistics, P .05; On-line Table 1 andOn-line Fig 1).
FPA showed better image quality than MSCT in assessing the
anterior and posterior crura of the stapes (On-line Fig 2), foot-
plate of the stapes (On-line Fig 2), incudostapedial joint (On-line
Fig 3), and stapedius muscle and anterior ligament of the malleus
(all statistics, P .05; On-line Table 1). No significant difference
in terms of image quality was found between MSCT and FPA in
the assessment of the remaining anatomic structures (On-line
Table 1). FPA had a significantly higher overall image quality
(summed score) thanMSCT (P .035; On-line Table 1). Data on
theobserver sensitivity and interobserver agreementare summarized
in On-line Table 3. The summed score of FPA correlated with the
SNR(R0.44,P .02),whilenocorrelationwas foundbetween the
summed scores of MSCT and SNR (R 0.21, P .26).
Radiation Dose Assessment
Doses of the TLD sites are reported in On-line Table 2 and repre-
sented in On-line Fig 4; equivalent doses and effective doses for
each organ are reported in Tables 1 and 2, respectively.
DISCUSSION
Image Quality Assessment
Our study demonstrates that FPA provides higher image quality
in the cross-sectional imaging of the temporal bone compared
with a 64-section MSCT scanner. To the best of our knowledge,
Table 1: Equivalent doses (HT) for each organ of interest
Sites FPA MSCT
Bone marrow 2.4 3.24
Esophagus 0.15 0.37
Thyroid 1.48 3.74
Skin 0.33 2.09
Bone surface 6.05 6.89
Salivary glands 32.44 57.26
Brain 21.33 32.71
Lymphatic nodes 0.69 1.15
Muscle 0.69 1.15
Extrathoracic region 12.93 26.6
Oral mucosa 15.71 25.21
Pituitary 24.31 45.84
Eyes 5.09 51.15
Eye lens 1.77 45.9
Table 2: Tissue-weighting factors and effective doses of FPA and
MSCT for each organ
Sites
Tissue-Weighting
Factors (ICRP
103 Version) FPA MSCT
Bone marrow 0.12 0.29 0.39
Esophagus 0.04 0.01 0.01
Thyroid 0.04 0.06 0.15
Skin 0.01 0.00 0.02
Bone surface 0.01 0.06 0.07
Salivary glands 0.01 0.32 0.57
Brain 0.01 0.21 0.33
Lymphatic nodes
Muscle 0.12 0.28 0.5
Extrathoracic region
Oral mucosa Mean dose on remainder organsa
Effective dose (mSv) 1.23 2.04
Note:—ICRP indicates International Commission on Radiological Protection.
a Remainder organs are: adrenals, extrathoracic region, gall bladder, heart, kidneys,
lymphatic nodes, muscle, oral mucosa, pancreas, prostate or uterus/cervix, small
intestine, spleen, thymus. For remainder organs a tissue-weighting factor of 0.05 is
assigned according to the IRCP 103 version. The effective dose for the extrathoracic
region and the oral mucosa, respectively, corresponds to the mean dose on remain-
der organs.
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no previous studies have assessed the image quality of FPA in
delineating normal temporal bone anatomy.
The image quality of FPCT prototypes or dedicated FPCT
scanners has already been assessed in isolated temporal bone
specimens, resulting in better image quality compared with
MSCT.1,3,13 However, these results are not clinically useful be-
cause FPCT prototypes are not available for clinical use in
humans; the use of dedicated FPCT scanners in isolated tem-
poral bone specimens does not represent the real clinical set-
ting.Whole-head specimens absorbmore low-energy photons,
and radiation penetration is lower because the mass between
the radiation source and the detector is greater.
A previous study showed that a dedicated FPCT scanner did
not provide improvement in image quality in scanning whole-
head temporal bone specimens compared with MSCT.1 Our re-
sults are partially in agreement with these results. Although the
overall image quality of FPA was better than MSCT, FPA im-
proved the visualization of some structures (ie, stapes, stapedius
muscle, anterior malleus ligament, chorda tympani), but it
showed a limited value in the visualization of other structures (ie,
modiolus, the interscalar septum of the cochlea, the tympanic
membrane, bone marrow of the malleus and incus). Some tech-
nical aspects are pertinent to understanding these heterogeneous
results.
The high isotropic spatial resolution of FPA (0.14  0.14 
0.14 mm) provided more detailed cross-sectional images and al-
lowed us to obtainmultiplanar reformationswith the same spatial
resolution as in the original plane. In contrast, MSCT had a lower
spatial resolution (0.64-mm thickness and 0.2 0.2mm in-plane
resolution), and the anisotropic voxel shape led to a loss of detail
in the MPR images. The higher spatial resolution of FPA was
particularly useful for the depiction of small bone structures such
as the stapes and its components but was less useful for the visu-
alization of larger bone structures, such as the malleus and incus,
which were well-visualized by MSCT.
FPA had different technical disadvantages compared with
MSCT, including a longer acquisition time,more susceptibility to
artifacts, and lower contrast resolution and SNR. The longer ac-
quisition time of FPA (25 versus 5.6 seconds) can render the scan-
ning more susceptible to motion artifacts. Beam-hardening and
scattering artifacts were evident in FPA, creating bright streaks in
the image. Beam-hardening occurs in high-attenuation tissue,
such as the temporal bone, where low-energy photons are more
easily absorbed and high-energy photons pass through.14 Thus,
beam transmission does not follow the simple exponential decay
seen with amonochromatic x-ray. FPA cannot use the same algo-
rithms that MSCT adopts to correct for beam-hardening because
they require that the complete object (ie, the temporal bone) fit
into the FOV; FPA uses a small FOV (20 25 cm) and does not
completely compute the temporal bone.15
Scattering artifacts are due to the deviation of some photons
when they pass through thewhole-head tissues. The diverted pho-
tons impact the wrong detector (ie, not the detector parallel to the
x-ray source), and tissue density information is distorted.1 In
FPA, unlike MSCT, scatter intensities may severely impair image
quality because the entire volume, as opposed to a few planes in
MSCT, contributes to the scattered radiation.4 Beam-hardening
and scattering artifacts explain why FPA visualized small bone
structures surrounded by soft-tissue (ie, the modiolus and inter-
scalar septum of the cochlea) or small soft-tissue structures sur-
rounded by bony structures (ie, bone marrow of the malleus and
incus) less optimally than MSCT. In addition, scattering artifacts
were responsible for the low contrast resolution of FPA,which did
not attain improved depiction of small soft-tissue structures im-
mersed in air space (ie, suspensory ligaments, tendons of the ten-
sor tympani and tympanic membrane) compared with MSCT, as
one could expect. The high susceptibility to artifacts explains the
higher image noise and the lower signal and SNRmeasured in the
FPA images. We demonstrated that when artifacts decreased and
SNR increased, the overall image quality of FPA improved.
Considering our results, it is important to define when the use
of FPA is preferable to MSCT for the cross-sectional imaging of
the temporal bone. FPA is recommended only in patients with
high compliance to avoid head motion artifacts due to the longer
acquisition time. We always preferred FPA in the assessment of
the middle and inner ear because it shows equal or better image
quality than MSCT in depicting almost all bony structures of di-
agnostic interest. Although FPA could fail in the assessment of the
modiolus and the interscalar septum because of motion, beam-
hardening, and scattering artifacts, we also recommend FPA for
the assessment of suspected cochlear malformations in pediatric
patients. In fact, beam-hardening and scattering artifacts are usu-
ally less evident in pediatric patients due to their smaller head
volume. In uncooperative pediatric patients, we perform FPA
with the patient under sedation in the same session with the MR
imaging study, if planned, to avoid 2 separate sedations. Other-
wise MSCT with low-dose protocol is preferred. FPA is highly
recommended in the assessment of cochlear implants and metal-
lic prostheses after middle ear reconstructive surgery, as previ-
ously reported in the literature.7-9 Regarding the cross-sectional
imaging of the outer ear, we use FPA for the assessment of the
bony external auditory canal, as in cases of suspected external
auditory canal atresia or osteoma, which may be associated with
middle ear malformations. In contrast, we do not use FPA for the
assessment of pathologies that can involve the soft tissues of the
periauricular region, such as malignant otitis externa because of
the low contrast resolution of FPA.
Radiation Dose Assessment
According to our results, the lower radiation dose is the main
advantage of FPA in the assessment of the temporal bone. Com-
paredwithMSCT, FPA showed a reduction of the effective dose of
up to 40% (1.23 versus 2.04 mSv). We observed that the equiva-
lent dose of FPA decreased approximately 76% for the lenses of
the eye and 40% for the thyroid, which are themost radiosensitive
tissues in the head and neck region.
To the best of our knowledge, no previous studies have com-
pared radiation doses between FPCT or FPA and MSCT in the
assessment of the temporal bone. In the literature, similar data
were only reported for FPCT in the assessment of themaxillofacial
region, reflecting the widespread use of FPCT in dental radiol-
ogy.10,16-19 In previous studies considering radiation exposure of
FPCT andMSCT in the assessment of the temporal bone, the dose
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was provided by themanufacturers2 or recorded from the scanner
console.13
The lower equivalent dose of FPA is due to 3main reasons: The
first is related to the scan parameters because the dose change is
approximately proportional to the square of the tube voltage (ki-
lovolt) and proportional to the current (milliampere).20 Thus, the
lower tube voltage of FPA determines a reduction of the dose
though its current is higher. Second, FPA has a smaller FOV than
MSCT, allowing a further reduction in exposure as well as scan-
ning of thewholemastoid area togetherwith themiddle and inner
ears, which may be essential for some diagnoses.13 Third, the
semicircular trajectory of our x-ray source, posterior to the head,
explains the conspicuous reduction in radiation dose to the lenses
of the eyes and the thyroid. Regions situated in the primary beam
of the x-ray source receive a higher dose than regions far from the
source.
Some limitations of our study must be acknowledged. We did
not perform awithin-subject analysis, with each patient undergo-
ing both examinations, for ethical reasons; however, this limita-
tion was overcome by enrolling a large number of subjects.We do
not know whether our results will be completely reproducible
with other angiography systems because of the different technol-
ogy and reconstruction algorithms provided by variousmanufac-
turers. Our image quality assessment was focused on the delinea-
tion of the normal ear anatomy, so we do not know if the
described improvements of FPA can improve the diagnosis of
pathologic processes. Finally, we did not compare the FPA system
andFPCT scanner, sowe donot know if the latter remains the first
choice for the temporal bone assessment.
CONCLUSIONS
FPA can be adopted for the cross-sectional imaging of the tempo-
ral bone, showing strengths and weaknesses compared with
MSCT. FPA can fail in depicting structures, as discussed in this
article, because of motion, beam-hardening, and scattering arti-
facts that impair the contrast resolution. However, due to its
higher spatial resolution, FPA showed equal or higher image qual-
ity than MSCT in assessing bony structures of considerable diag-
nostic interest for radiologists. The lower radiation dose is an
additional advantage of FPA, showing a reduction of the effective
dose of up to 40% compared with MSCT.
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